Figure S2. A and B: qRT-PCR assays for the URRCC mRNA level in 786-O and OSRC-2 cells after transfection of sh-control, sh-URRCC-1, and sh-URRCC-2. C: MTT assays after transfection of sh-URRCC compared with sh-control in 786-O cells. D: Representative images and the numbers of invasive cells per high-power field reduced by the transfection of sh-URRCC in 786-O compared to sh-control groups. (PDF 96 kb
Clear cell renal cell carcinoma (ccRCC) is a common aggressive malignant tumor of the urinary system...
Table S1. lncRNAs significantly associated with the overall survival. Table S2. Patient and tumor ch...
Clear cell renal cell carcinoma (ccRCC) comprises more than 80% of all renal cancers and when metast...
Figure S4. A: Bioinformatics analysis of potential FOXO3 binding site on URRCC promoter by online so...
Table S3. BX649059 expression in ccRCC and normal renal samples from TCGA KIRC dataset. (XLS 27 kb
Table S4. Clinical characteristics of 116 ccRCC patients according to URRCC expression levels. (XLSX...
Figure S1. A: Flow chart of selecting dysregulated lncRNAs from two public RCC Dataset (GSE46699 and...
Table S9. EGFL7 expression in ccRCC and normal renal samples from TCGA KIRC dataset. (XLS 26 kb
Table S10. FOXO3 expression and paitients' survival time from TCGA KIRC dataset. (XLS 19 kb
Table S8. JMY expression and paitientsâ survival time from TCGA KIRC dataset. (XLS 19 kb
Gene chip co-expression network. LncRNAs-mRNAs co-expression network was constructed according to th...
Abstract Background The aberrant expression of long noncoding RNAs (lncRNAs) has recently emerged as...
Supplement S2. (a) The fusion types of three renal carcinoma cell lines were detected by PCR. (b, c)...
Additional file 1: Figure S1. High-throughput RNA sequencing and related analysis in highly and poor...
Figure S8. (A) Representative images of Western blot analysis of pAKT S473 and pERK T202/Y204 protei...
Clear cell renal cell carcinoma (ccRCC) is a common aggressive malignant tumor of the urinary system...
Table S1. lncRNAs significantly associated with the overall survival. Table S2. Patient and tumor ch...
Clear cell renal cell carcinoma (ccRCC) comprises more than 80% of all renal cancers and when metast...
Figure S4. A: Bioinformatics analysis of potential FOXO3 binding site on URRCC promoter by online so...
Table S3. BX649059 expression in ccRCC and normal renal samples from TCGA KIRC dataset. (XLS 27 kb
Table S4. Clinical characteristics of 116 ccRCC patients according to URRCC expression levels. (XLSX...
Figure S1. A: Flow chart of selecting dysregulated lncRNAs from two public RCC Dataset (GSE46699 and...
Table S9. EGFL7 expression in ccRCC and normal renal samples from TCGA KIRC dataset. (XLS 26 kb
Table S10. FOXO3 expression and paitients' survival time from TCGA KIRC dataset. (XLS 19 kb
Table S8. JMY expression and paitientsâ survival time from TCGA KIRC dataset. (XLS 19 kb
Gene chip co-expression network. LncRNAs-mRNAs co-expression network was constructed according to th...
Abstract Background The aberrant expression of long noncoding RNAs (lncRNAs) has recently emerged as...
Supplement S2. (a) The fusion types of three renal carcinoma cell lines were detected by PCR. (b, c)...
Additional file 1: Figure S1. High-throughput RNA sequencing and related analysis in highly and poor...
Figure S8. (A) Representative images of Western blot analysis of pAKT S473 and pERK T202/Y204 protei...
Clear cell renal cell carcinoma (ccRCC) is a common aggressive malignant tumor of the urinary system...
Table S1. lncRNAs significantly associated with the overall survival. Table S2. Patient and tumor ch...
Clear cell renal cell carcinoma (ccRCC) comprises more than 80% of all renal cancers and when metast...